Polymeric bile acid derivatives inhibit Hepatitis B and D virus and NTCP transport
US11701369B2 · kind B2 · utility
0Cited by
7References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 2015 |
| Grant date | Jul 18, 2023 |
| Priority date | — |
| Expiry date | Sep 28, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J71/0047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides for treating HBV or HDV infection or inhibiting human sodium taurocholate co-transporting polypeptide (hNTCP) with a polymeric bile acid or salt thereof, and pharmaceutical compositions comprising a polymeric bile acid or salt thereof, and a second HBV or HDV medicament.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.